DNA X, Inc. (SONM) Return on equity 2018–2023
DNA X, Inc. (SONM) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
-0.4%FY2023 · since FY2018: 24.9% → -0.4%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2023 | -0.4% | +69.9 pp |
| FY2022 | -70.3% | +137.1 pp |
| FY2021 | -207.3% | -102.0 pp |
| FY2020 | -105.4% | -4.1 pp |
| FY2019 | -101.2% | -126.1 pp |
| FY2018 | 24.9% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice